In a landmark move for international healthcare policy, a coalition of twelve leading economies has ratified a unified framework for the clinical application of biological additive manufacturing as of January 2026. This move, spearheaded by the FDA and the European Medicines Agency, aims to resolve the long-standing ambiguity regarding the classification of printed tissues as either medical...
Spanish 
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt